Gout
Latest News
Gout Increases the Risk for a Wide Range of Cardiovascular Diseases
This association was more pronounced in women than in men, and gout amplified the risk for CVD in younger individuals to a greater extent.
From the Journals
Preventing Gout Flares and Hospitalizations Means Targeting These Serum Urate Levels
The findings “support the value of target serum urate levels in gout flare prevention in primary care, where most gout patients are treated.”
From the Journals
Tool Uses Genetics to Assist With Diagnosis of Early Inflammatory Arthritis
The tool may aid in accelerating accurate diagnosis and getting patients on the right treatments earlier.
From the Journals
Dieting and Gout: Intensive Weight Loss Not Especially Helpful for Symptoms
Researchers found an association between weight loss and a corresponding reduction in serum urate, but more weight loss did not result in positive...
Feature
Evidence Grows for SGLT2 Inhibitors in Rheumatology
Sodium-glucose cotransporter-2 (SGLT2) inhibitors are not approved to treat gout, lupus, or lupus nephritis, but clinicians are uncovering signs...
Conference Coverage
CPPD nomenclature is sore subject for gout group
G-CAN hopes to standardize terminology and finally oust ‘pseudo’ vernacular.
Conference Coverage
Gout: Studies support early use of urate-lowering therapy, warn of peripheral arterial disease
Urate-lowering drugs might be OK early on; gout may boost peripheral arterial disease.
News from the FDA/CDC
Approximately 20% of U.S. adults are diagnosed with arthritis
New data show disproportionate arthritis prevalence among women, veterans, non-Hispanic White individuals, and those aged 45 years and older.
From the Journals
Adverse event rates compared for colchicine, NSAIDs when starting allopurinol for gout
Patients receiving prophylactic colchicine or NSAIDs with initiation of allopurinol for gout have more adverse events than those who receive no...
From the Journals
Colchicine still needed to prevent gout flares in allopurinol ‘start-low, go-slow’ strategy
Patients taking colchicine had fewer gout flares than did those taking placebo for the first 6 months, but the number evened out between the two...
From the Journals
Diabetes drug class appears to reduce recurrent gout flares
Previously associated with a lower incidence of gout, SGLT2 inhibitors for the first time also appear to reduce gout flare recurrence and excess...